Tretiak N N, Babenko T F, Gaĭdukova S N, Zverkova A S, Beschastnaia S P
Lik Sprava. 1998 Mar-Apr(2):93-6.
Results are submitted of study of the effectiveness of inclusion into the treatment program for patients with chronic lymphoid leukemia of specific (thymalin) and unspecific (plasmapheresis) means and modes of immune correction, which made for more rapid attaining clinical and hematological compensation by comparison with chemotherapeutic agents only. Furthermore, the method of combined use of drugs, attempted for the first time, permitted the functional activity of the lymphoid system to be improved, with the clinical and hematological compensation being achieved in a shorter space of time.
提交了关于将特异性（胸腺素）和非特异性（血浆置换）免疫纠正手段及方式纳入慢性淋巴细胞白血病患者治疗方案有效性的研究结果。与仅使用化疗药物相比，这些手段能使患者更快实现临床和血液学缓解。此外，首次尝试的联合用药方法能够改善淋巴系统的功能活性，并在更短时间内实现临床和血液学缓解。
